Apollo
logo
  1. Home
  2. salt
  3. Eptacog Alfa

Eptacog Alfa

About Eptacog Alfa

Eptacog Alfa is a prescription injection used to control and prevent bleeding episodes in patients with rare blood clotting disorders, such as haemophilia with inhibitors or specific clotting factor deficiencies. It works by restoring the body's natural ability to form blood clots during active bleeds or surgical procedures. This specialised therapy helps manage severe bleeds and protects patients from dangerous blood loss.

You will typically inject this medication as needed during a bleeding event or on a regular schedule prescribed by your doctor to prevent bleeding. Because it is given as an intravenous injection, food intake does not affect how this medicine works in your body. To support your treatment, incorporating low-impact joint-strengthening exercises and avoiding high-risk physical activities can help reduce the frequency of spontaneous bleeding episodes.

Some individuals may experience mild side effects while using Eptacog Alfa, such as redness at the injection site, mild fever, or headache. However, you must contact your doctor immediately if you experience signs of a serious blood clot, such as sudden chest pain, shortness of breath, or leg swelling. Always monitor your body closely after each injection and report any unusual symptoms to your medical team.

Do not take this if you have a known severe allergy to this medication or to mouse, hamster, or bovine proteins, which are used during the manufacturing process. Talk to your doctor before starting treatment if you have a history of heart disease, a recent stroke, or active blood clots, as these conditions may increase your risk of complications.

Avoid using other clotting factor medicines alongside Eptacog Alfa unless specifically directed by your specialist, as combining these treatments can dangerously increase your risk of unwanted blood clots. It is also important to consult your doctor before using this medication if you are pregnant, breastfeeding, or an elderly patient, as these specific groups may require customised monitoring.
 

Uses of Eptacog Alfa

Eptacog Alfa is used in the treatment of Bleeding disorders. The detailed uses of Eptacog Alfa are as follows: • Hemophilia A and B with Inhibitors: Eptacog Alfa is used to control bleeding episodes in patients with hemophilia A or B who have developed inhibitors against standard clotting factors. It bypasses the need for factors VIII or IX by directly activating the clotting cascade to promote hemostasis. • Congenital Factor VII Deficiency: Eptacog Alfa is used for individuals born with a deficiency of clotting factor VII. It replaces the missing factor and helps form stable clots at bleeding sites, reducing the risk of prolonged or spontaneous bleeding. • Acquired Hemophilia and Surgical Bleeding: Eptacog Alfa is used to manage bleeding in patients with acquired hemophilia or during surgeries where normal clotting is impaired. It supports rapid clot formation and minimizes blood loss, even in complex or high-risk procedures.

Medicinal Benefits

Eptacog Alfa is used to treat bleeding and to prevent bleeding after surgery or other important treatments. It is used in people who were born with haemophilia (inherited bleeding disorder) and did not normally respond to factors VIII or IX treatment, has acquired haemophilia, Factor VII deficiency, or Glanzmann’s thrombasthenia (a bleeding disorder), and the condition cannot be treated effectively with platelet transfusion, or if platelets are not readily available. Eptacog Alfa may also be given to treat heavy bleeding after delivery of the baby, even if the mother does not have a bleeding disorder. Eptacog Alfa contains Eptacog alfa, a blood coagulation factor that works by making the blood clot at the site of bleeding when the body’s own clotting factors are not working. Early treatment with Eptacog Alfa reduces the amount and duration of bleeding. Eptacog Alfa works in all types of bleeds, including joint bleeds.

Directions for Use

  • Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
  • Eptacog Alfa will be administered by a healthcare professional. In some cases, it may be given to use at home. Follow your doctor’s instructions if you use this injection at home.
  • Do not use if the solution is cloudy, contains particles, or if the vial is damaged.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Eptacog Alfa

Common Side Effects (Usually mild):

  • Pain, redness, or swelling at the injection site
  • Mild fever or chills
  • Headache
  • Nausea


Serious Side Effects (Call a doctor right away):

  • Signs of a blood clot, such as sudden pain or swelling in a leg, shortness of breath, sudden severe headache, or chest pain
  • Severe allergic reactions, including hives, swelling of the face or throat, wheezing, or difficulty breathing
  • Dizziness or feeling faint

Medicines Containing this Salt

View All

Drug Warnings

  • Inspect the solution before administration: After reconstitution, the solution should be clear and colourless. Do not use it if it appears cloudy, discoloured, or contains visible particles.
  • Use proper injection technique: Rotate injection sites whenever possible to reduce the risk of vein irritation, scarring, or local injection-site reactions.
  • Use sterile equipment every time: Never reuse needles, syringes, infusion sets, or transfer devices. Always use new sterile equipment for each administration to minimise the risk of infection.
  • Maintain a treatment record: Keep a log of each infusion, including the date, dose, batch (lot) number, and reason for treatment (such as a bleeding episode or routine prophylaxis), and share it with your healthcare provider during follow-up visits.
  • Carry medical identification: Always carry a medical alert card or bracelet stating that you have a bleeding disorder and are receiving Eptacog Alfa so appropriate treatment can be provided in an emergency.
     

Drug Interactions

  • Coagulation factor concentrates (such as Factor VIII or IX complexes): Combining these with Eptacog Alfa may significantly increase the risk of forming dangerous, life-threatening blood clots.
  • Antifibrinolytics (such as tranexamic acid or aminocaproic acid): Using these medicines close to the time of injecting Eptacog Alfa can enhance clot stability but may also increase the risk of unwanted blood clots in the blood vessels.

Drug-Drug Interactions Checker List:

Safety Advice

  • Safety Warning

    Alcohol

    caution

    It is not known if alcohol affects Eptacog Alfa. However, limit or avoid consumption of alcohol while on treatment with Eptacog Alfa.

  • Safety Warning

    Pregnancy

    caution

    If you are pregnant or planning pregnancy, inform your doctor before receiving Eptacog Alfa. Your doctor may prescribe this medicine if the benefits outweigh the risks.

  • Safety Warning

    Breast Feeding

    caution

    If you are breastfeeding, inform your doctor before receiving Eptacog Alfa. Your doctor may prescribe this medicine if the benefits outweigh the risks.

  • Safety Warning

    Driving

    caution

    It is not known whether Eptacog Alfa can affect the driving ability. Drive or operate machinery only if you are alert after taking this medicine.

  • Safety Warning

    Liver

    caution

    If you have a pre-existing or a history of liver disease, inform your doctor before receiving Eptacog Alfa.

  • Safety Warning

    Kidney

    caution

    If you have a pre-existing or a history of kidney diseases, inform your doctor before receiving Eptacog Alfa.

  • Safety Warning

    Children

    consult your doctor

    Limited information is available. Please consult your doctor for more information.

Habit Forming

No

Diet & Lifestyle Advise

  • Stay physically active: Engage in low-impact exercises such as walking, swimming, or cycling to strengthen the muscles around your joints and help reduce the risk of bleeding. Avoid high-impact or contact sports unless approved by your doctor.
  • Maintain a healthy body weight: Keeping your weight within a healthy range reduces stress on your joints and may help decrease the frequency of joint bleeding episodes.
  • Practice good oral hygiene: Brush your teeth with a soft-bristled toothbrush and floss gently to maintain healthy gums and reduce the risk of oral bleeding.
  • Schedule regular dental check-ups and inform your dentist about your bleeding disorder.
  • Avoid medicines that increase bleeding risk: Unless specifically prescribed by your doctor, avoid aspirin, ibuprofen, naproxen, and other NSAIDs, as they can interfere with normal clotting. Speak with your healthcare provider about safer alternatives for pain relief.
  • Protect yourself from injuries: Use appropriate protective equipment during physical activities, avoid situations that increase your risk of trauma, and seek medical advice promptly if you experience signs of internal bleeding or joint swelling.
     

Patients Concern

Disease/Condition Glossary

Bleeding disorder: It is a group of conditions in which the body’s clotting process does not work properly due to a lack of clotting factors. It can lead to prolonged and heavy bleeding. In most cases, bleeding disorders are inherited; however, in rare cases, they are developed later in life.

FAQs

Eptacog Alfa is used to treat bleeding disorders.

Eptacog Alfa works by making the blood clot at the site of bleeding when the body’s own clotting factors are not working.

Do not use Eptacog Alfa at the same time as prothrombin complex concentrates or rFXIII (recombinant factor XIII). Talk to your doctor before using Eptacog Alfa if you also use Factor VIII or IX products.

Eptacog Alfa may cause blood clots at the site of injection or in the blood vessels of the kidney, liver, lungs or limbs. Consult your doctor if you experience any signs of a blood clot, such as red and painful swelling in the leg, abdominal pain, and difficulty breathing.

In case of mild or moderate bleeding episodes, Eptacog Alfa may be prescribed for use at home if required. Do not stop using Eptacog Alfa or adjust the dose without checking with your doctor. You should not continue home treatment for longer than 24 hours without consulting your doctor. Contact your doctor immediately if the bleeding is not controlled within 24 hours.

Eptacog Alfa is used to control and prevent bleeding episodes, especially during surgeries, in patients with bleeding disorders such as hemophilia with inhibitors, congenital factor VII deficiency, or Glanzmann's thrombasthenia. Talk to your doctor to see if this treatment is right for your condition.

Eptacog Alfa is injected directly into a vein (intravenously). A healthcare provider can give this injection, or you can learn to administer it at home after receiving proper training. Talk to your doctor or pharmacist to learn the correct injection technique.

Yes, unopened vials of Eptacog Alfa can often be stored at room temperature (up to 25°C) for a limited time, but they must not be frozen. Always check the package insert for specific temperature limits, and talk to your doctor or pharmacist for guidance on safe storage.

Swelling, warmth, or pain in a leg can be a sign of a deep vein blood clot, which is a serious potential side effect. You must seek immediate emergency medical care if you notice these symptoms. Talk to your doctor as soon as possible about any unusual changes after injection.

The safety of Eptacog Alfa during pregnancy has not been fully established. It should only be used during pregnancy if the potential benefits outweigh the risks. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.

Some patients with haemophilia develop 'inhibitors,' which are antibodies that block standard factor treatments from working. Eptacog Alfa bypasses these blocked pathways to help the blood clot directly. Talk to your doctor to understand why this specific treatment was chosen for you.

No, you should avoid taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen while using Eptacog Alfa, as these medicines can thin your blood and increase the risk of bleeding. Talk to your doctor or pharmacist for safe pain relief options.

Do not inject the medicine if the solution appears cloudy, discoloured, or contains visible particles. It should be completely clear and colourless. Discard the vial safely and prepare a new one. Talk to your doctor or pharmacist if you experience issues with reconstitution.

Author Details

Doctor image
We provide you with authentic, trustworthy and relevant information.
Apollo 247 Floating Button